SGN-CD33A plus hypomethylating agents: A novel, well-tolerated regimen with high remission rate in frontline unfit AML Meeting Abstract
| Authors: | Fathi, A. T.; Erba, H. P.; Lancet, J. E.; Stein, E. M.; Walter, R. B.; DeAngelo, D. J.; Faderl, S.; Jillella, A. P.; Ravandi, F.; Advani, A. S.; Bixby, D.; Kovacsovics, T. J.; O'Meara, M. M.; Kennedy, D. A.; Stein, A. S. |
| Abstract Title: | SGN-CD33A plus hypomethylating agents: A novel, well-tolerated regimen with high remission rate in frontline unfit AML |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019001206 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.454.454 |
| Notes: | Meeting Abstract: 454 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
